News

December 15, 2011 – A single center study recently published in the November 15, 2011 issue of the Journal of the American College of Cardiology (JACC) suggests that both cardiac computed tomography (cardiac CT) and cardiovascular magnetic resonance (CMR) are superior to transthoracic echocardiography (TTE) in the assessment of patients undergoing transcatheter aortic valve implantation (TAVI).

Home December 15, 2011
Home
Technology

December 14, 2011 β€” Toshiba America Medical Systems Inc. unveiled the Adaptive Iterative Dose Reduction 3-D (AIDR 3-D), its next generation dose reduction technology, at RSNA 2011. Still pending 510(k) approval from the U.S. Food and Drug Administration (FDA), the software will be available on Toshiba’s Aquilion One, Aquilion Premium and Aquilion Prime (also pending 510(k) clearance) systems.

Home December 14, 2011
Home
Technology

December 14, 2011 β€” Aptus Endosystems Inc. announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX Aortic Securement System. Aptus develops technology for endovascular aneurysm repair (EVAR).

Home December 14, 2011
Home
News

December 14, 2011 β€” A new survey reveals many cardiologists believe angioplasty for hospital heart patients should be allowed even if no heart surgeon is present to perform emergency surgery if needed. The survey, conducted by U.S. News & World Report and theheart.org showed two-thirds of respondents agreed with this change to the current rules.

Home December 14, 2011
Home
News

December 14, 2011 β€” Flagstaff Medical Center (FMC) has begun enrollment for a new program, Care Beyond Walls and Wires, an initiative extending patient care beyond the walls of the hospital or physician's office. In collaboration with Qualcomm Inc., and its Wireless Reach initiative β€” along with Zephyr Technology, Verizon Wireless, and the National Institutes of Health (NIH) β€” the program uses advanced 3G wireless technology and health-monitoring devices to enhance patient care for congestive heart failure (CHF) or other related conditions.

Home December 14, 2011
Home
News

December 14, 2011 β€” The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) trial were presented at the American Heart Association Scientific Sessions 2011 conference in Orlando, Fla. This prospective, blinded multi-center study was designed to provide a third independent validation of the Corus CAD blood-based gene expression test.

Home December 14, 2011
Home
Technology

Steris and Toshiba America Medical Systems formed an alliance to offer advanced vascular, cardiovascular, pediatric and neurosurgical hybrid surgical suites to healthcare systems seeking the latest patient-focused interventions.

Home December 13, 2011
Home
Technology

December 13, 2011 β€” Royal Philips Electronics announced that iDose, the latest generation of its iterative reconstruction technique, has nearly 500 sales.

Home December 13, 2011
Home
Technology

December 13, 2011 β€” Siemens announced its computed tomography (CT) iterative reconstruction algorithm SAFIRE – Sinogram Affirmed Iterative Reconstruction – has been cleared for domestic sale by the U.S. Food and Drug Administration (FDA). This new generation of image reconstruction software and hardware allows for a robust reduction of radiation dose in CT examinations.

Home December 13, 2011
Home
Technology

December 13, 2011 β€” Toshiba America Medical Systems Inc. has introduced DICOM Radiation Dose Structured Report on all new Infinix-i vascular X-ray systems. The new feature automatically records radiation dose information from every X-ray event, from beginning to end, based on each pedal push administered by the clinician.

Home December 13, 2011
Home
Technology

December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide range of peripheral angioplasty procedures. The Charger PTA Balloon Catheter is Boston Scientific's third new peripheral balloon catheter introduced in 2011.

Home December 13, 2011
Home
Technology

Boston Scientific recently announced U.S. Food and Drug Administration (FDA) approval for the Promus Element Plus everolimus-eluting platinum chromium coronary stent system, the company's next-generation drug-eluting stent (DES) technology. The Promus Element, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on a platinum chromium (PtCr) platform with the DES market-leading everolimus drug. The company plans to begin marketing the product in the United States immediately.

Home December 12, 2011
Home
News

December 12, 2011 – Hansen Medical UK Ltd., a subsidiary of Hansen Medical Inc., a developer of robotic technology for accurate 3-D control of catheter movement, announced a new multi-center worldwide survey evaluating the safety and efficacy of atrial fibrillation (AF) ablation by robotic navigation with the Sensei robotic catheter system. The abstract was presented by Luigi Di Biase, M.D., Ph.D., in a poster session at the American Heart Association Scientific Sessions 2011 at the Orange County Convention Center in Orlando, Florida on November 14th, 2011.

Home December 12, 2011
Home
News

December 12, 2011 - CardioMEMS announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion heart failure monitoring system. It is the first wireless, permanently implantable device that allows cardiologists to monitor heart failure (HF) patients from their homes. While the panel agreed with a 9-1 vote that the CardioMEMS technology is safe, the majority did not vote positively that the system is effective and that reasonable assurance of the risks associated with the device outweigh the potential clinical benefits of the technology.

Home December 12, 2011
Home
News

December 9, 2011 β€” Maquet announced Thursday it has restructured its U.S. Sales and Services Unit to meet the broader needs of customers across all areas of clinical care. As part of this restructuring, the company now offers a comprehensive disease therapy team dedicated to servicing customers who are building a hybrid operating room (OR).

Home December 09, 2011
Home
Subscribe Now